Cilostazol Reduces Angiographic Restenosis After Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol Study
Author(s) -
Osamu Iida,
Hiroyoshi Yokoi,
Yoshimitsu Soga,
Naoto Inoue,
Kenji Suzuki,
Yoshiaki Yokoi,
Daizo Kawasaki,
Kan Zen,
Kazushi Urasawa,
Yoshiaki Shintani,
Akira Miyamoto,
Keisuke Hirano,
Yusuke Miyashita,
Taketsugu Tsuchiya,
Norihiko Shinozaki,
Masato Nakamura,
Takaaki Isshiki,
Toshimitsu Hamasaki,
Shinsuke Nanto
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.000711
Subject(s) - cilostazol , medicine , restenosis , lesion , target lesion , cardiology , aspirin , angiography , stent , surgery , radiology , percutaneous coronary intervention , myocardial infarction
It remains unclear whether cilostazol, which has been shown to improve the clinical outcomes of endovascular therapy for femoropopliteal lesions, also reduces angiographic restenosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom